MS
Mohammad Shadab Khan
About Mohammad Shadab Khan
Data last updated:
Mohammad Shadab Khan is a Director at Sylas Pharma Solutions Private Limited (since 2019) and Director at Deniz Life Science Private Limited (since 2026). The companies operate in E-Commerce. The largest current company by reported revenue is Sylas Pharma Solutions Private Limited at ₹5.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sylas Pharma Solutions Private Limited U52520DL2019PTC359564 | Director | 31 Dec 2019 | 2019 | ₹5.7 Lakh (FY 2025) | Active |
| Deniz Life Science Private Limited U46497RJ2026PTC110490 | Director | 08 Jan 2026 | 2026 | Active |
Board colleagues of Mohammad Shadab Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Imran Alam | 08654654 | Sylas Pharma Solutions Private Limited | Director |
| Anil Kumar | 11473557 | Deniz Life Science Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammad Shadab Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammad Shadab Khan
Mohammad Shadab Khan currently holds 2 directorships: Sylas Pharma Solutions Private Limited (Director, since 31 Dec 2019, revenue ₹5.7 Lakh (FY 2025)); Deniz Life Science Private Limited (Director, since 08 Jan 2026).
Mohammad Shadab Khan was first appointed on 31 Dec 2019 as Director at Sylas Pharma Solutions Private Limited. The most recent appointment on record is 08 Jan 2026 at Deniz Life Science Private Limited.
The current boards of Mohammad Shadab Khan's companies include Imran Alam (Sylas Pharma Solutions Private Limited), Anil Kumar (Deniz Life Science Private Limited).